Ayrak Pharma LLP - electrnoics in Nagpur, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAR-3835 Incorporated 20 December 2019 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Limited Liability Partnership electrnoics
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
7 yrs
Est. 2019
Designated partners
2
As per MCA filings
Last financials
Mar 2022
Balance sheet date
LLP status
Active
MCA master data
Registrar
Nagpur
ROC office
Incorporated
20 Dec 2019
Date of incorporation
Entity type
LLP
As registered with MCA

About Ayrak Pharma LLP

Data last updated:

Ayrak Pharma LLP is a limited liability partnership (LLP) based in Nagpur, Maharashtra, India. It operates in the precision and optical instruments segment of the electronics sector. It was incorporated on 20 December 2019 and has been in existence for over 7 years.

The LLP is registered with the Registrar of Companies (ROC), Nagpur, under LLPIN AAR-3835.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners Omkar Sachin Mamidwar and Palash Dilip Gangamwar.

Its latest statement of accounts is for the year ended 31 March 2022. The registered office is at Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.

Company details

LLPIN AAR-3835
Incorporation Date 20 December 2019
Total Obligation of Contribution β‚Ή1 Lakh
ROC Nagpur
Company Status Active

Contact details

Ayrak Pharma LLP's registered office is in Nagpur, Maharashtra.

  • Registered Address
    Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025
  • Industry
    Electrnoics, Precision & Optical Instruments, Manufacturing, Medical
Comprehensive company report
Ayrak Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Ayrak Pharma LLP

FY 2022 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Ayrak Pharma LLP, buy the company report.

Designated partners of Ayrak Pharma LLP

Ayrak Pharma has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Omkar Sachin MamidwarDesignated Partner20 Dec 20196 Years 11 MonthsCurrent
Palash Dilip GangamwarDesignated Partner20 Dec 20196 Years 11 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ayrak Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ayrak Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ayrak Pharma LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Omkar Sachin Mamidwar was appointed as Designated Partner on 20 Dec 2019.

AGM
Ayrak Pharma Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Filing
Ayrak Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Nagpur.
Appointed
Omkar Sachin Mamidwar was appointed as Designated Partner.
Appointed
Palash Dilip Gangamwar was appointed as Designated Partner.
Incorporation
20 Dec 2019
Ayrak Pharma Llp was registered on 20 Dec 2019 with Roc Nagpur & aged 6 years 11 months as per MCA records.

Frequently asked questions

Ayrak Pharma is an active limited liability partnership based in Nagpur, Maharashtra, India. The LLP works in precision and optical instruments, within the electronics industry. It was incorporated on 20 December 2019 (7+ years old) and is registered under LLPIN AAR-3835.

Ayrak Pharma has 2 current designated partners:

The latest financial statements of Ayrak Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2020 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Ayrak Pharma is AAR-3835. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Ayrak Pharma was incorporated on 20 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.

Omkar Sachin Mamidwar was appointed as Designated Partner on 20 Dec 2019. Palash Dilip Gangamwar was appointed as Designated Partner on 20 Dec 2019.

The registered office of Ayrak Pharma is at Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.

Ayrak Pharma operates in the electronics industry, in the precision and optical instruments segment.

Ayrak Pharma can be reached at its registered office: Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.

Ayrak Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.